Clinical syndrome caused by a number of brain disorders which cause memory loss, decline in some other aspect of cognition, and difficulties with activities of daily living
Aetiology
Some of the more common causes of dementia are:
Alzheimer’s disease - most common cause, 50-70% of cases of dementia
Usually occurs in old age - 1/5 of individuals over 80 years old are affected
Vascular dementia - accounts for ~25%
Brain damage due to cerebrovascular disease: either major stroke, multiple smaller unrecognised strokes (multi-infarct) or chronic changes in smaller vessels (subcortical dementia)
Dementia with Lewy bodies - about 15% of cases
Deposition of abnormal protein (⍺-synuclein) within neurons in the brain stem and neocortex
Frontotemporal dementia - < 5% of cases
Specific degeneration/atrophy of the frontal and temporal lobes of the brain
Potentially treatable dementias (<5%)
Metabolic e.g. uraemia
Toxic e.g. alcohol
Vitamin deficiency - B12 and thiamine
Traumatic - severe or repeated brain injury
Intracranial lesions e.g. subdural haematoma, tumours
Infections e.g. HIV
Endocrine e.g. hypothyroidism
Psychiatric - depression causing 'pseudodementia'
Rare causes
Huntington’s disease
Autosomal dominant trait
Onset usually between 30 and 50 years - age dependant penetrance
Parkinson's disease
CJD
Pathophysiology
Molecular pathology and aetiology of Alzheimer's disease
The pathological hallmarks of AD include:
Loss of cortical neurones
Neurofibrillary tangles
Senile plaques - extracellular protein deposits containing amyloid β protein
Initial symptoms generally forgetfulness
Degeneration of medial hippocampus + later parietal lobes: forgetfulness → apraxia/visuospatial difficulties
Genetics have been implicated in AD
A first-degree relative with AD confers a doubled lifetime risk of AD
There are rare autosomal dominant monogenic early-onset forms of familial AD with high penetrance, caused by mutations in specific genes
Genes which have been linked to the development of AD include: the E4 allele of the apolipoprotein E gene, point mutations in the APP gene, and mutations in presenilin (PS)-1 and 2
The presence of three copies of the APP gene on chromosome 21 in Down’s syndrome patients is responsible for the high incidence of AD in that condition - onset in 3rd or 4th decade
<65 years - early onset AD, genetic influences, may be atypical presentation
<65 years - sporadic AD, environmental > genetic influences, usually typical initial forgetfulness